coronary artery disease (cad) arterial hypertension - cad... · coronary artery disease (cad)...
TRANSCRIPT
3/4/2015
1
Coronary Artery Disease (CAD)Coronary Artery Disease (CAD)
Arterial HypertensionArterial Hypertension
Blagoi Marinov, MD, PhDBlagoi Marinov, MD, PhD
Pathophysiology Dept.Pathophysiology Dept.
Medical University of PlovdivMedical University of Plovdiv
Coronary arteriesCoronary arteries
3/4/2015
2
OO22 regimen of the heartregimen of the heart
TDP of left ventricle
Coronaryresistance
Heartrate
Contractile state
Wall stress
О2 extraction
О2 content
Coronaryblood flow
О2 requirements О2 delivery
rate
Risk Risk ffactors for Atherosclerosisactors for Atherosclerosis
Major Lesser, Uncertain, or Nonquantitated
Nonmodifiable
Increasing age Obesity
Male gender Physical inactivity
Family history Stress ("type A" personality)
Genetic abnormalities Postmenopausal estrogen deficiency
High carbohydrate intake
Potentially ControllablePotentially Controllable
Hyperlipidemia Alcohol
Hypertension Lipoprotein Lp(a)
Cigarette smoking Hardened (trans)unsaturated fat intake
Diabetes Chlamydia pneumoniae
3/4/2015
3
Atherosclerosis – the most important etiologic factor
PPathogenetic events, and clinical complications of athogenetic events, and clinical complications of atherosclerosis in the coronary arteriesatherosclerosis in the coronary arteries
3/4/2015
4
DefinitionDefinition
IschemiaIschemia refersrefers toto anan insufficientinsufficient amountamountofof bloodblood SinceSince thethe coronarycoronary arteriesarteries areareofof bloodblood.. SinceSince thethe coronarycoronary arteriesarteries arearethethe onlyonly sourcesource ofof bloodblood forfor thethe heartheart musclemuscleitsits bloodblood supplysupply willwill suffersuffer tremendouslytremendously..
Myocardial IschemiaMyocardial Ischemia
Myocardium becomes ischemic within 10 Myocardium becomes ischemic within 10 d f l id f l iseconds of coronary occlusionseconds of coronary occlusion
Working Working cells remain viable for up to 20 cells remain viable for up to 20 minutesminutes–– Anaerobic mechanisms kick inAnaerobic mechanisms kick in
Lactic acidLactic acidLactic acidLactic acid
Free radical damage, especially after reperfusionFree radical damage, especially after reperfusion
3/4/2015
5
Ischemic episodeIschemic episode
SeveritySeverity
DurationDuration
FrequencyFrequency
Pain
Ischemia
CAD classificationCAD classificationStable anginaStable anginaU t bl iU t bl iUnstable anginaUnstable anginaAtypical anginaAtypical angina (Prinzmetal)(Prinzmetal)Myocardial infarctionMyocardial infarctionAtherosclerotic Atherosclerotic myocardiosclerosismyocardiosclerosismyocardiosclerosismyocardiosclerosisSilent ischemiaSilent ischemiaSudden cardiac deathSudden cardiac death
3/4/2015
6
Stable anginaStable angina
Chest pain with exertionChest pain with exertionpp
May radiate, may have diaphoresis, SOB, pallorMay radiate, may have diaphoresis, SOB, pallor
Relief with rest or nitratesRelief with rest or nitrates
Increased О2
demand
Decreased О2
delivery
Morphological substrateMorphological substrate
3/4/2015
7
Treatment for Stable AnginaTreatment for Stable Angina
DrugDrugNit tNit t–– NitratesNitrates
–– Beta blockersBeta blockers
–– Calcium Channel BlockersCalcium Channel Blockers
–– StatinsStatins
Invasive cardiologyInvasive cardiologyInvasive cardiology Invasive cardiology –– PTCA PTCA
–– StentStent
SurgerySurgery–– BypassBypass
Acute Coronary SyndromeAcute Coronary Syndrome
Atherosclerotic Plaque
Stable Plaque Unstable Plaque
Stable Angina Acute Coronary Syndrome
SustainedI h i
TransientI h i / Ischemia
MyocardialInfarction
Ischemia/UnstableAngina
Necrosis
FrequencyFrequencySeveritySeverityMagnitudeMagnitudeDurationDuration
3/4/2015
8
atherosclerotic plaqueatherosclerotic plaque
blood clot sticking to plaque
narrowed lumen
Advances in interventional cardiologyAdvances in interventional cardiology
3/4/2015
9
PTCAPTCA: Percutaneous Transluminal : Percutaneous Transluminal Coronary AngioplastyCoronary Angioplasty
Invasive, but nonsurgical technique to Invasive, but nonsurgical technique to reduce frequency and severity of chest reduce frequency and severity of chest discomfortdiscomfort May also be used during evolving MIMay also be used during evolving MI
Procedure performed under fluoroscopic Procedure performed under fluoroscopic guidance in cardiac cath labguidance in cardiac cath labguidance in cardiac cath labguidance in cardiac cath lab Balloon inflation may be repeated until lesion is Balloon inflation may be repeated until lesion is
reduced or eliminatedreduced or eliminated
Stents may be placed at time of procedureStents may be placed at time of procedure
CABGCABG: Coronary Artery Bypass Graft: Coronary Artery Bypass Graft
Most common cardiac surgeryMost common cardiac surgeryIndicated for patients who do not respond to Indicated for patients who do not respond to medical management of CAD or when disease medical management of CAD or when disease progression is evidentprogression is evidentTo be bypassed vessels should have proximal To be bypassed vessels should have proximal lesions with > 70% occlusionlesions with > 70% occlusionMost effective when good ventricular functionMost effective when good ventricular functionMost effective when good ventricular function Most effective when good ventricular function remains and ejection fraction is more than 40remains and ejection fraction is more than 40--50%50%Requires Cardiopulmonary bypass during Requires Cardiopulmonary bypass during surgerysurgery
3/4/2015
10
Myocardial infarctionMyocardial infarction ((MIMI))
Ischemic necrosis of the part of myocardium
Transmural Transmural
NonNon--transmuraltransmural ((subendocardial,subendocardial, withoutwithout QQ wavewave))
p y(more frequently on the left).
G l h t i tiGeneral characteristics
Myocardium becomes hypoxic
Shift to Anaerobic Respiration
Waste products release/hypoxic injury
Cardiac output impaired
Pathogenesis of MIPathogenesis of MI
Time !
3/4/2015
11
Myocardial ChangesMyocardial Changes
Myocardial Myocardial stunningstunning–– Temporary loss of contractility that persists for Temporary loss of contractility that persists for
hours to dayshours to days
Myocardial Myocardial hibernationhibernation–– Chronically ischemic; Chronically ischemic; myocytesmyocytes are are
hibernating to preserve function until hibernating to preserve function until g pg pperfusion can be restoredperfusion can be restored
Myocardial Myocardial remodellingremodelling–– Loss of contractility mediated by Loss of contractility mediated by AngAng II, II,
catecholaminescatecholamines, and inflammatory cytokines, and inflammatory cytokines
Signs and symptoms of MISigns and symptoms of MI
3/4/2015
13
Change in serum enzymesChange in serum enzymes
ImmediateImmediate Post MI Post MI TxTx
Reduce myocardial workloadReduce myocardial workload
Prevent Prevent RemodelingRemodeling
Reduce chances of Reduce chances of reocclusionreocclusion
Reduce oxidative stress (reperfusion injury)Reduce oxidative stress (reperfusion injury)
3/4/2015
14
LongLong--termterm Post MI TreatmentPost MI Treatment
LifestyleLifestyleDietDiet–– DietDiet
–– Exercise Exercise –– Cardiac RehabCardiac Rehab
–– Stress managementStress management
DrugsDrugs–– Antiplatelet: aspirin, clopidogrelAntiplatelet: aspirin, clopidogrelp p , p gp p , p g
–– Beta blockerBeta blocker
–– Statin medicationStatin medication
–– Treat risk factors (HTN, lipid, smoke, etc.)Treat risk factors (HTN, lipid, smoke, etc.)
Complications of MIComplications of MI
Disorders of rhythm and conductionDisorders of rhythm and conduction SupraventricularSupraventricular
VentricularVentricular ((tachicardiatachicardia, , fibrillationsfibrillations))
Rupture of post infarction aneurismRupture of post infarction aneurism
PericarditisPericarditis ((Dressler syndromeDressler syndrome))
Post infarction anginaPost infarction angina (20(20--30 %)30 %)
3/4/2015
15
PrognosisPrognosis of MIof MI
Acute MI is associated with a Acute MI is associated with a 30% mortality rate30% mortality rate; half of ; half of the deaths occur prior to arrival at the hospital.the deaths occur prior to arrival at the hospital.p pp p
An additional An additional 55--10%10% of survivors of survivors die within the first yeardie within the first yearafter their MI.after their MI.
Approximately Approximately half of all patientshalf of all patients with an MI are with an MI are rehospitalized within 1 yearrehospitalized within 1 year of their index event.of their index event.
Overall, Overall, prognosis is highly variableprognosis is highly variable and depends largely and depends largely on the extent of the infarct, the residual LV function, and on the extent of the infarct, the residual LV function, and whether the patient underwent revascularization.whether the patient underwent revascularization.
Screening of different forms Screening of different forms of CADof CAD
Stress testStress test CoronaryCoronaryangiographyangiography
ElectroElectro--cardiogramcardiogram
3/4/2015
16
ARTERIAL HYPERTENSIONARTERIAL HYPERTENSION
Blood pressure levels*Blood pressure levels*
SystolicSystolic DiastolicDiastolic LevelLevel
120120 8080 OptimalOptimal
< 130< 130 < 85< 85 NormalNormal
130130--139139 8585-- 8989 Normal borderlineNormal borderline
140 140 --159159 90 90 -- 9999 Mild hypertensionMild hypertension
160160 179179 100100 109109 Moderate hypertensionModerate hypertension160160--179179 100100--109109 Moderate hypertensionModerate hypertension
> 179> 179 > 109> 109 Severe hypertensionSevere hypertension
> 140> 140 < 90< 90Maximum or systolic Maximum or systolic
hypertensionhypertension
*Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and treatment of High Blood Pressure
3/4/2015
17
CCardiac output and peripheral resistance ardiac output and peripheral resistance in blood pressure regulationin blood pressure regulation
3/4/2015
18
The burden of hypertensionThe burden of hypertension(distribution by age and sex*)(distribution by age and sex*)
*CDC. National Health Survey, 2005
Types of HypertensionTypes of Hypertension
Essential Hypertension (Primary)
Secondary Hypertension
3/4/2015
19
Risk factors for arterial Risk factors for arterial hypertensionhypertension
Primary
NaCl rich diet Stress
Secondary
Hypercholesterolemia Hypercholesterolemia Prediabetic state Overweight Sedentary lifestyle Alcohol abuse
3/4/2015
20
Medium caliber arteries are Medium caliber arteries are the most affectedthe most affected
Genetic backgroundGenetic background
3/4/2015
21
Pathogenetic units Pathogenetic units for arterial hypertensionfor arterial hypertension
Neurogenic RenalEndocrine
Hypothalamo-pituitary axis
g
Pressor dominancein CNS
Sympathetic nervous system
Renal
RAAS Renal
depressor system
Cardiovascular
Total peripheral resistance (TPR)Hypervolemia
Cardiac output (CO)
Pathogenesis of Hypertension
3/4/2015
22
Symptoms and signsSymptoms and signs
Almost always asymptomaticAlmost always asymptomatic
Dyspnea most commonDyspnea most common
Headache,Dizziness,Tinnitus,FaintingHeadache,Dizziness,Tinnitus,Fainting not not correlated with hypertensioncorrelated with hypertension
Symptoms poorly correlated to degree of Symptoms poorly correlated to degree of hypertensionhypertensionhypertensionhypertension
3/4/2015
23
Consequence of HTNConsequence of HTN
(CHF)
Staging of arterial hypertensionStaging of arterial hypertension
Labile hypertensionLabile hypertensionLabile hypertensionLabile hypertensionIncreased COIncreased CO
Normal TPRNormal TPR
Stable hypertensionStable hypertensionIncreased TPRIncreased TPR
Normal CONormal CONormal CONormal CO
Organ damage and complicationsOrgan damage and complicationsCompensatedCompensated
DecompensatedDecompensated
3/4/2015
24
Complications of HypertensionComplications of Hypertension
It can always get worse …It can always get worse …
RenalA t l l h iti
CardiovascularCoarctation of aorta
Secondary Hypertension
Acute glomerulonephritisChronic renal diseasePolycystic diseaseRenal artery stenosisRenal artery fibromuscular dysplasiaRenal vasculitisRenin-producing tumorsEndocrineAdrenocortical hyperfunction
Coarctation of aortaPolyarteritis nodosa (or other vasculitis)Increased intravascular volumeIncreased cardiac outputRigidity of the aortaNeurologic (Psychogenic)Increased intracranial pressureSleep apneaAdrenocortical hyperfunction
Exogenous hormones Sympathomimetics, PheochromocytomaAcromegalyHypothyroidism (myxedema)Hyperthyroidism (thyrotoxicosis)Pregnancy-induced
p pAcute stress, including surgery
3/4/2015
25
Antihypertensive AgentsAntihypertensive Agents
General Classes of Agents:General Classes of Agents:General Classes of Agents:General Classes of Agents: DiureticsDiuretics
Sympatholytic agents Sympatholytic agents blockers (central)blockers (central)
blockers (peripheral)blockers (peripheral)
VasodilatorsVasodilators
Agents which interfere with the RAASAgents which interfere with the RAAS ACE inhibitorsACE inhibitors
Angiotensin receptor blockersAngiotensin receptor blockers
Thank you !